Dear CT Insider,
Annual screening with low-dose CT (LDCT) has been shown to be an effective way to catch lung cancer early. But there are still individuals who would benefit from screening who aren't getting it.
That's why a team from Baptist Cancer Center in Memphis, TN, says that combining LDCT screening with a lung nodule program -- that is, one that would identify suspicious lung findings on any imaging modality and send them for further workup -- could boost LDCT utilization for lung cancer screening and thus save even more lives, according to research we're highlighting in this edition's Insider Exclusive.
After you've read our exclusive, check out our report on how Ukrainian radiologists are coping with the Russian attack on their country, what Russian radiologists think about their government's actions, and how professional societies are weighing in on the conflict.
Additionally, take a look at our coverage of the ECR 2022 Overture, including a presentation on how CT offers a safe alternative to coronary angiography for computer-aided detection (CAD) diagnosis and how imaging is best used to screen for COVID-19-induced kidney damage.
Finally, discover what contributing writer Sandy Coffta of Healthcare Administrative Partners USA has to say about a decision by the U.S. Centers for Medicare and Medicaid Services to expand coverage for lung cancer screening, and how an artificial intelligence algorithm uses chest CT and laboratory results to predict the severity of COVID-19 disease.
CT is a tried-and-true modality that helps clinicians offer excellent patient care every day. Stay up to date on its developments by visiting our CT Community regularly. And if you have CT topics you'd like to see covered, I invite you to contact me.
